Ticker: HALO

Company: HALOZYME THERAPEUTICS INC

Person: Henderson Jeffrey William, director

Transaction date: April 1, 2025

Reporting date: April 1, 2025

Average share price: 64.05

Sold 503.0 shares for 32217.15